1

                                                                    EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the use in this Registration Statement on Form S-4 of
ICN Pharmaceuticals, Inc. of our report dated March 1, 2001, except for Note 12,
as to which the date is March 15, 2001, which includes an emphasis-of-a-matter
paragraph related to the Company's change in method of accounting for its
investment in ICN Yugoslavia, a previously consolidated subsidiary, relating to
the financial statements and financial statement schedule of ICN
Pharmaceuticals, Inc., which appears in such Registration Statement. We also
consent to the reference to us under the heading "Independent Accountants" in
such Registration Statement.

                                          /s/ PRICEWATERHOUSECOOPERS LLP
                                          PricewaterhouseCoopers LLP

Orange County, California

August 21, 2001